SCHEMBL515443

SCHEMBL515443

CCNC(CCCCN)C(=O)O.N=C=O.N=C=O

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.50
SLC6A5 Q9Y345 1/20 0.43
GSR P00390 1/20 0.42
RNPEP Q9H4A4 1/20 0.41
TLR2 O60603 1/20 0.40
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
CPB2 Q96IY4 11/20 0.39
GGT1 P19440 1/20 0.38
SIRT6 Q8N6T7 1/20 0.38
SIRT1 Q96EB6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29176458 1.00 FOLH1 (0.50) FOLH1SLC6A5GSRRNPEPTLR2
SCHEMBL29233127 1.00 FOLH1 (0.50) FOLH1SLC6A5GSRRNPEPTLR2
SCHEMBL2151316 0.92 FOLH1 (0.57) FOLH1SLC6A5GSRRNPEPTLR2
SCHEMBL2151319 0.92 FOLH1 (0.57) FOLH1SLC6A5GSRRNPEPTLR2
Water SCHEMBL28303756 0.90 FOLH1 (0.56) FOLH1SLC6A5GSRRNPEPTLR2
Hydrochloric Acid SCHEMBL29268898 0.90 FOLH1 (0.56) FOLH1SLC6A5GSRRNPEPTLR2
Hydrochloric Acid SCHEMBL28514579 0.90 FOLH1 (0.56) FOLH1SLC6A5GSRRNPEPTLR2
Hydrochloric Acid SCHEMBL3647090 0.90 FOLH1 (0.56) FOLH1SLC6A5GSRRNPEPTLR2
Ammonia Solution, Strong SCHEMBL4951257 0.90 FOLH1 (0.56) FOLH1SLC6A5GSRRNPEPTLR2
SCHEMBL29233125 0.88 FOLH1 (0.44) FOLH1SLC6A5GSRRNPEPTLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024076323-A2 SYNTHESIS AND APPLICATION OF SENSITIVITY ENHANCING POLYMERIC SYSTEMS IN MAGNETIC LEVITATION METHOD IZMIR YUKSEK TEKNOLOJI ENSTITUSU REKTORLUGU (TR) 2024-04-11 WO claimed
EP-4284454-A1 MULTI-PUTTY BONE HEMOSTATIC AND ADHESIVE COMPOSITIONS FOR USE IN METHODS OF INSTALLING AND SECURING SURGICAL HARDWARE IN BONES Abyrx, Inc. (US) 2023-12-06 EP claimed
US-11672885-B2 Therapeutic putties containing additives including processed human blood plasma ABYRX, INC. (US) 2023-06-13 US claimed
WO-2022165319-A1 MULTI-PUTTY BONE HEMOSTATIC AND ADHESIVE COMPOSITIONS FOR USE IN METHODS OF INSTALLING AND SECURING SURGICAL HARDWARE IN BONES ABYRX, INC. (US) 2022-08-04 WO claimed
EP-3821916-A1 TWO PUTTY SETTABLE BONE HEMOSTATIC AND ADHESIVE COMPOSITION Abyrx, Inc. (US) 2021-05-19 EP claimed
US-20240226372-A1 HYDROPHILIC POLY(THIOKETAL) URETHANE SCAFFOLDS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-07-11 US disclosed
CN-118215651-A Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition 旭化成株式会社 2024-06-18 CN disclosed
WO-2024076323-A2 SYNTHESIS AND APPLICATION OF SENSITIVITY ENHANCING POLYMERIC SYSTEMS IN MAGNETIC LEVITATION METHOD IZMIR YUKSEK TEKNOLOJI ENSTITUSU REKTORLUGU (TR) 2024-04-11 WO disclosed
WO-2024064891-A1 MOLDS FOR SETTABLE MULTI-COMPONENT COMPOSITIONS AND METHOD OF FORMING SAID COMPOSITIONS ABYRX, INC. (US) 2024-03-28 WO disclosed
US-11911533-B2 Tissue repair laminates POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2024-02-27 US disclosed
US-11877539-B2 Sprayable polymer membrane for agriculture COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2024-01-23 US disclosed
EP-3727198-B1 SOFT TISSUE IMPLANT POCKET POLYNOVO BIOMATERIALS PTY LTD (AU) 2024-01-17 EP disclosed
EP-1720926-A1 POLYMER COMPOSITIONS FOR DUAL OR MULTI STAGED CURING COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2006-11-15 EP disclosed
EP-1720925-A1 BIOCOMPATIBLE POLYMER COMPOSITIONS FOR DUAL OR MULTISTAGED CURING Commonwealth Scientific and Industrial Research Organization (CSIRO) (AU) 2006-11-15 EP disclosed
US-20060051394-A1 Biodegradable polyurethane and polyurethane ureas MOORE TIMOTHY G 2006-03-09 US disclosed
US-20050238611-A1 Cosmetic compositions and their use INTERCOS S.P.A. (IT) 2005-10-27 US disclosed
EP-1588686-A1 Cosmetic compositions and their use Intercos S.p.A. (IT) 2005-10-26 EP disclosed
WO-2005085312-A1 BIOCOMPATIBLE POLYMER COMPOSITIONS FOR DUAL OR MULTISTAGED CURING COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2005-09-15 WO disclosed
WO-2005085313-A1 POLYMER COMPOSITIONS FOR DUAL OR MULTI STAGED CURING COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2005-09-15 WO disclosed
US-20050197422-A1 Biocompatible polymer compositions for dual or multi staged curing POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197422-A1 Biocompatible polymer compositions for dual or multi staged curing PCNA, CAD, BMP2 FOLH1 1941/4885SLC6A5 4129/4885GSR 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.